MedPath

Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study

Phase 2
Conditions
Dyslipidemias
LDL Hyperlipoproteinemia
Interventions
Drug: Red Rice Yeast Extract
Registration Number
NCT03607383
Lead Sponsor
Saint-Joseph University
Brief Summary

Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10.

The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.

Detailed Description

Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Studies performed on American and Chinese populations have shown positive results. These studies need confirmation in different populations. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10. The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Adult patient (>18 years)
  • Indication to mild or moderate statin based on AHA 2013 guidelines
  • Treatment naïve
Exclusion Criteria
  • Allergy to rice
  • Renal or hepatic terminal disease
  • Any contra indication to statin treatment
  • Pregnancy wish during study period
  • Familial hypercholesterolemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Red rice yeast groupRed Rice Yeast ExtractRed rice yeast based product will be provided under the brand name Molval Fort, one pill a day, for 8 weeks, for a moderate intensity treatment equivalent according the American College of Cardiology/American Heart Association (ACC/AHA) guidelines definitions
Statin groupStatinStatin choice is done at the discretion of the treating physician for a moderate intensity treatment equivalent according the American College of Cardiology/American Heart Association (ACC/AHA) guidelines definitions, for 8 weeks
Primary Outcome Measures
NameTimeMethod
LDL reductioneight weeks

after an eight week treatment, cholesterol LDL levels' reduction is compared in the two groups

Secondary Outcome Measures
NameTimeMethod
incidence of side effectseight weeks

after eight weeks of treatment, the incidence of side effects is studied among the red rice yeast group

Trial Locations

Locations (1)

Saint Anthony Primary Care Center

🇱🇧

Jdeide, Lebanon

© Copyright 2025. All Rights Reserved by MedPath